CNBC’s Leslie Picker reports on the upcoming pricing of Medline's IPO.
Breakdown
- Medline's IPO could be the largest global debut of 2025
- IPO expected to price at high end, valuing Medline at $55 billion 30s
- Medline was taken private in 2021 in a major LBO by private equity firms 30s
- Company has grown sales annually since the 1960s at 18% CAGR 1m 29s
- Risks include business concentration, product quality, and pricing pressures 1m 43s